Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.60
-0.93 (-9.76%)
At close: Apr 28, 2026, 4:00 PM EDT
8.70
+0.10 (1.22%)
After-hours: Apr 28, 2026, 7:35 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $455.90 million as of April 28, 2026. Its market cap has increased by 1,024.09% in one year.
Market Cap
455.90M
Enterprise Value
356.57M
1-Year Change
1,024.09%
Ranking
Category
Stock Price
$8.60
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $455.90M, an increase of 593.46%. That is a compound annual growth rate of 55.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 505.21M | 83.31% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 527.69M |
| Fulcrum Therapeutics | 514.15M |
| Zura Bio | 513.30M |
| Upstream Bio | 505.56M |
| XOMA Royalty | 500.10M |
| MiMedx Group | 496.21M |
| Verastem | 486.65M |
| Valneva SE | 485.14M |